Annotation Detail for ITK
Basic Information
Top
Pathway ID | Pathway Name |
---|
hsa04670 | Leukocyte transendothelial migration |
hsa04062 | Chemokine signaling pathway |
hsa04660 | T cell receptor signaling pathway |
Pathway ID | Pathway Name |
---|
| Signaling in Immune system |
Pathway ID | Pathway Name |
---|
200003 | Fc-epsilon receptor I signaling in mast cells |
200098 | Class I PI3K signaling events |
200022 | TCR signaling in naive CD4+ T cells |
Pathway ID | Pathway Name |
---|
500481 | Generation of second messenger molecules |
Desease ID | Desease Name |
---|
1809 | HIV infection |
2074 | Asthma |
Desease Name |
---|
Lymphoproliferative syndrome, EBV-associated, autosomal, 1 |
Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C027309 |
3,4,5,3',4',5'-hexachlorobiphenyl |
3,4,5,3',4',5'-hexachlorobiphenyl results in increased expression of ITK mRNA | increases expression | 16050139
|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of ITK mRNA | affects expression | 17562736
|
C014949 |
acetylhydrazine |
acetylhydrazine results in decreased expression of ITK mRNA | decreases expression | 15282401
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in increased expression of ITK mRNA | increases expression | 16050139
|
C029424 |
hydrazine |
hydrazine results in decreased expression of ITK mRNA | decreases expression | 15282401
|
D018038 |
Sodium Selenite |
Sodium Selenite results in decreased expression of ITK mRNA | decreases expression | 18175754
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
2.04 | 20127859 20464547 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
2.82 | 6695378 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
4.36 | 10982225 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
4.49 | 19183758 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
1.40 | 18445737 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
2.00 | 17474063 20146248 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
1.40 | 3084413 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
2.12 | 20419170 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
2.75 | 10977129 |
MESH:D019457 |
Chromosome Breakage |
|
Sodium Selenite |
5.17 | 15894690 |
MESH:D003920 |
Diabetes Mellitus |
|
Sodium Selenite |
4.06 | 16285004 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
4.08 | 14986274 12594235 16177239 11739529 15968718 19164858 19739265 14550746 11421492 11529661 12958197 19923254 16081117 18713872 16485898 11743745 14725611 12392966 19085960 10663392 16109766 12153990 17522070 17562736 19416960 2444490 11461765 16393943 16227642 19420014 11834606 19370779 12705907 15619225 16781746 10774834 18071297 12540782 10915739 11287661 17906064 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Sodium Selenite |
4.08 | 15131321 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
4.62 | 19426721 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
2.07 | 16530937 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
4.19 | 16983495 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
2.80 | 20471113 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
2.95 | 16870215 |
MESH:D007333 |
Insulin Resistance |
|
Sodium Selenite |
3.47 | 14714311 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
2.36 | 12587719 15629191 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
1.69 | 19460945 16610002 19014921 11587558 12969438 16611625 19784758 12587719 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
3.54 | 17185352 16871587 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
2.13 | 21137059 20195826 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
1.57 | 20464547 18569708 18816296 20135361 20869020 6695378 20064080 17053015 18520028 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Sodium Selenite |
4.41 | 14737004 |
OMIM:613011 |
LYMPHOPROLIFERATIVE SYNDROME, EBV-ASSOCIATED, AUTOSOMAL, 1 |
marker/mechanism |
|
| |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
3.98 | 19513568 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
3.43 | 16381670 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
2.30 | 11141357 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
3.14 | 18514411 |
MESH:D010146 |
Pain |
|
Acetaminophen |
2.65 | 16870215 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
3.15 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
Sodium Selenite |
3.15 | 18760546 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
2.49 | 10029692 19755658 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
1.56 | 20155912 2093021 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
2.28 | 17053015 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
3.33 | 10982225 |
Drugbank ID |
Action |
Drug Name |
Description |
---|
DB02010 |
- |
Staurosporine |
Enzyme Inhibitors |